Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshinobu Takakura

Showing results (1-10 of 214) with videos related to

Pageof 22
Sort By:
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|March 5, 2019
[Summary of a Report from the Science Council of Japan]Yoshinobu Takakura
Drug Metabolism and Pharmacokinetics|February 1, 2005
Analysis methods and recent advances in nonlinear pharmacokinetics from in vitro through in loci to in vivoKiyoshi Yamaoka, Yoshinobu Takakura
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 27, 2022
Strategies for persistent retention of macromolecules and nanoparticles in the blood circulationYoshinobu Takakura, Yuki Takahashi
Pharmacology & Therapeutics|January 26, 2023
Extracellular vesicle-based therapeutics: Extracellular vesicles as therapeutic targets and agentsYuki Takahashi, Yoshinobu Takakura
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 24, 2006
Suppression of tumor growth by intratumoral injection of short hairpin RNA-expressing plasmid DNA targeting beta-catenin or hypoxia-inducible factor 1alphaYuki Takahashi, Makiya Nishikawa, Yoshinobu Takakura
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|February 3, 2007
[Development of heat shock proteins with controlled distribution properties and their application to vaccine delivery]Makiya Nishikawa, Seiji Takemoto, Yoshinobu Takakura
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|October 6, 2007
[In vivo siRNA delivery to tumor cells and its application to cancer gene therapy]Yuki Takahashi, Makiya Nishikawa, Yoshinobu Takakura
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 10, 2012
Self-assembling CpG DNA nanoparticles for efficient antigen delivery and immunostimulationSakulrat Rattanakiat, Makiya Nishikawa, Yoshinobu Takakura
International Journal of Pharmaceutics|October 13, 2005
Cellular uptake and activation characteristics of naked plasmid DNA and its cationic liposome complex in human macrophagesIkuko Yamane, Makiya Nishikawa, Yoshinobu Takakura
Frontiers in Bioscience (Scholar Edition)|December 29, 2011
Development of safe and effective nonviral gene therapy by eliminating CpG motifs from plasmid DNA vectorYuki Takahashi, Makiya Nishikawa, Yoshinobu Takakura
Pageof 22

Showing results (1-10 of 214) with videos related to

Sort By:
Pageof 22
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|March 5, 2019
[Summary of a Report from the Science Council of Japan]Yoshinobu Takakura
Drug Metabolism and Pharmacokinetics|February 1, 2005
Analysis methods and recent advances in nonlinear pharmacokinetics from in vitro through in loci to in vivoKiyoshi Yamaoka, Yoshinobu Takakura
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 27, 2022
Strategies for persistent retention of macromolecules and nanoparticles in the blood circulationYoshinobu Takakura, Yuki Takahashi
Pharmacology & Therapeutics|January 26, 2023
Extracellular vesicle-based therapeutics: Extracellular vesicles as therapeutic targets and agentsYuki Takahashi, Yoshinobu Takakura
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 24, 2006
Suppression of tumor growth by intratumoral injection of short hairpin RNA-expressing plasmid DNA targeting beta-catenin or hypoxia-inducible factor 1alphaYuki Takahashi, Makiya Nishikawa, Yoshinobu Takakura
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|February 3, 2007
[Development of heat shock proteins with controlled distribution properties and their application to vaccine delivery]Makiya Nishikawa, Seiji Takemoto, Yoshinobu Takakura
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|October 6, 2007
[In vivo siRNA delivery to tumor cells and its application to cancer gene therapy]Yuki Takahashi, Makiya Nishikawa, Yoshinobu Takakura
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 10, 2012
Self-assembling CpG DNA nanoparticles for efficient antigen delivery and immunostimulationSakulrat Rattanakiat, Makiya Nishikawa, Yoshinobu Takakura
International Journal of Pharmaceutics|October 13, 2005
Cellular uptake and activation characteristics of naked plasmid DNA and its cationic liposome complex in human macrophagesIkuko Yamane, Makiya Nishikawa, Yoshinobu Takakura
Frontiers in Bioscience (Scholar Edition)|December 29, 2011
Development of safe and effective nonviral gene therapy by eliminating CpG motifs from plasmid DNA vectorYuki Takahashi, Makiya Nishikawa, Yoshinobu Takakura
Pageof 22